Inventor · disambiguated record
Ron C. Kelly
Also filed as: KELLY RON C · KELLY RON CHRISTOPHER
13 granted patents·8 pending applications·59 citations·filing 2007–2025
89Inventor score
Top patents by PatentIndex Score
21 records- 0195US11827635B2Solid state formsAMGEN INC·Filed 2021·Granted Nov 28, 2023·11 cites·16 claims
- 0295US11236091B2Solid state formsAMGEN INC·Filed 2020·Granted Feb 1, 2022·21 cites·25 claims
- 0393US11465969B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2019·Granted Oct 11, 2022·16 cites·32 claims
- 0492US11926592B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2022·Granted Mar 12, 2024·8 cites·21 claims
- 0590US12398133B2Solid state formsAMGEN INC·Filed 2023·Granted Aug 26, 2025·1 cites·42 claims
- 0686US12421234B1Solid state formsAMGEN INC·Filed 2025·Granted Sep 23, 2025·0 cites·29 claims
- 0786US12415806B1Solid state formsAMGEN INC·Filed 2025·Granted Sep 16, 2025·0 cites·22 claims
- 0882US12473329B2Methods directed to crystalline biomoleculesAMGEN INC·Filed 2024·Granted Nov 18, 2025·0 cites·19 claims
- 0971US2024199550A1Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2024·Application pending·0 cites
- 1066US8084605B2Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use thereforKELLY RON C·Filed 2007·Granted Dec 27, 2011·2 cites·77 claims
- 1166US2024013869A1Predicting Shelf Life Stability of Lyophilized Drug ProductsAMGEN INC·Filed 2021·Application pending·0 cites
- 1259US2025115622A1Crystalline Forms Of An MCL-1 InhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 1358US2025122224A1Crystalline Salt and Solvate Forms Of Murizatoclax (AMG 397)AMGEN INC·Filed 2023·Application pending·0 cites
- 1454US12252486B2Solid state formsAMGEN INC·Filed 2020·Granted Mar 18, 2025·0 cites·54 claims
- 1551US11958882B2Methods directed to crystalline biomoleculesAMGEN INC·Filed 2018·Granted Apr 16, 2024·0 cites·10 claims
- 1650US2022257607A1Formulations and dosages for administering a compound that inhibits mcl1 proteinAMGEN INC·Filed 2020·Application pending·0 cites
- 1749US2007208173A1Crystalline hydrates of cefdinir calcium saltKELLY RON CHRISTOPHER·Filed 2007·Application pending·0 cites
- 1848US2010324279A1Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosineANDRES PATRICIA M J·Filed 2008·Application pending·0 cites
- 1946US12000915B2Method for conducting solid state NMR on macromolecule-containing solid state formulationsAMGEN INC·Filed 2020·Granted Jun 4, 2024·0 cites·20 claims
- 2042US12187700B2Polymorphs and cocrystals of a cardiac troponin activatorAMGEN INC·Filed 2020·Granted Jan 7, 2025·0 cites·39 claims
- 2137US2012197018A1Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use thereforKELLY RON C·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →